Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacoepidemiology: the industry's perspective.

H H Tilson1

  • 1Epidemiology, Information and Surveillance Division, Burroughs Wellcome Co., Research Triangle Park, NC 27709.

The Journal of Rheumatology. Supplement
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeutics.

Clinical pharmacology and therapeutics·2007
Same author

Public health physicians: an endangered species.

American journal of preventive medicine·2001
Same author

Proactive safety surveillance.

Pharmacoepidemiology and drug safety·2001
Same author

Heralding a change: field action reports.

American journal of public health·2000
Same author

Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.

JAMA·1996
Same author

Implications for managed care organizations of the Merck and Medco consent.

Medical interface·1996

The pharmaceutical industry actively monitors drug safety, partnering with academia and government. Utilizing expertise and large databases, they analyze safety signals to protect public health.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Pharmacoepidemiology
  • Public Health

Background:

  • The pharmaceutical industry holds essential expertise and ownership of medicinal products.
  • Industry is uniquely positioned to receive and evaluate critical drug safety information.
  • Spontaneous voluntary reporting systems are central to identifying potential drug safety issues.

Purpose of the Study:

  • To highlight the pharmaceutical industry's central role in ensuring medication safety.
  • To emphasize the collaborative efforts between industry, academia, and government in pharmacovigilance.
  • To underscore the importance of large automated databases in evaluating drug safety signals.

Main Methods:

  • Leveraging industry expertise in drug development and evaluation.

Related Experiment Videos

  • Participating in spontaneous voluntary reporting systems.
  • Employing pharmacoepidemiology and structured epidemiological studies.
  • Utilizing large automated databases for signal detection and analysis.

    • Main Results:

    • Industry acts as a key partner in generating signals of potential drug safety problems.
    • Collaborative research with academia and government enhances the examination of safety signals.
    • Large automated databases are crucial for effective pharmacoepidemiological analysis.

    Conclusions:

    • The pharmaceutical industry is a vital partner in maintaining drug safety and protecting public health.
    • A unified perspective on public health is essential, without a separate "industry" viewpoint.
    • Continued development and application of pharmacoepidemiology are critical for robust drug safety surveillance.